Becker's Healthcare September 17, 2020
Five oncologists discuss key clinical innovations that are helping advance cancer care.
Editor’s note: Responses have been edited for clarity and length and are presented alphabetically.
Question: What is the most promising clinical innovation in cancer care today?
Craig Bunnell, MD, CMO of Dana-Farber Cancer Institute in Boston
The field of cancer therapy is being transformed by our deeper understanding of the genetic basis of cancer and the interactions between cancer and the immune system. This understanding has allowed us to both personalize cancer therapy, targeting a patient’s specific cancer, and to harness the patient’s immune system to recognize the cancer and augment its efforts to attack it.
In contrast to historic cancer therapies, like chemotherapy, which are nonspecific and...